Physician profile
Patrick J Camodeca
NPI 1013915248
$2,244.23
in general payments reported to CMS, 2019-2025
12 companies · $887 in 2025
The $887 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $89.61 · 2023: $327 · 2024: $664 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,878.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $643.02 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Smith+Nephew, INC. | $521.97 | 2024-2025 | Grafix Pl, Oasis, Stravix |
| Mimedx Group, INC. | $231.07 | 2025 | |
| Organogenesis INC. | $230.70 | 2023-2024 | Puraply |
| Reapplix INC. | $148.08 | 2025 | 3c Patch Kit - Box |
| Integra Lifesciences Corporation | $103.14 | 2019 | |
| Osiris Therapeutics INC. | $94.23 | 2019 | |
| Solventum Corporation | $79.72 | 2025 | Snap, Activ.A.C. |
| Misonix INC | $59.85 | 2020 | |
| Amniox Medical, INC. | $54.79 | 2019 | |
| Medela LLC | $53.58 | 2023 | Invia Motion Endure |
| Angiodynamics, INC. | $24.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Camodeca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.